Lv1
40 积分 2022-06-01 加入
Current status of drugs targeting PDGF/PDGFR
2天前
已完结
CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer
7天前
已完结
Homogeneous multi-payload antibody–drug conjugates
2个月前
已完结
FcRn inhibitors: Transformative advances and significant impacts on IgG-mediated autoimmune diseases
3个月前
已完结
FcRn Inhibitor Therapies in Neurologic Diseases
3个月前
已完结
Characteristics of Carcinoembryonic Antigen-Related Cell Adhesion Molecules and Their Relationship to Cancer
3个月前
已完结
IL-2-loaded Polypeptide Nanoparticles for Enhanced Anti-cancer Immunotherapy
5个月前
已完结
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
9个月前
已完结
Microenvironment-responsive anti-PD-L1 × CD3 bispecific T-cell engager for solid tumor immunotherapy
9个月前
已完结
An oncolytic virus–T cell chimera for cancer immunotherapy
10个月前
已完结
皖公网安备34019202002308
